Protein and mRNA expression level of IL-38 and correlation with IL-36R in pediatric asthmatic patients.

Q3 Medicine
Basima Q Alsaadi, Mayada H Ali, Fatima H Abbas, Duaa F Al-Mashhadani
{"title":"Protein and mRNA expression level of IL-38 and correlation with IL-36R in pediatric asthmatic patients.","authors":"Basima Q Alsaadi, Mayada H Ali, Fatima H Abbas, Duaa F Al-Mashhadani","doi":"10.1177/10932607261495881","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundPediatric asthma is a respiratory disease involving bronchial hyperresponsiveness to risk factors, influenced by genetic and environmental factors.<b>Objective:</b> This study investigated IL-38/IL-36R in pediatric asthma. Samples from 140 children aged 1-10 years, including 80 patients and 60 controls, were analyzed. IL-38 mRNA expression was assessed by qRT-PCR, while serum IL-38 and IL-36R were measured by ELISA.ResultsRevealed significant increase serum level of IL-38 74.80± 11.583pg/ml in asthmatic patients compare to control 59.33± 11.833pg/ml (P=0.01) while serum level of IL-36R in patients 226.26 ±88.07 pg/ml compare to control group167.4250 ±55.03pg/ml, results of expression of mRNA level of IL-38 shows significantly increased in asthmatic patients 2 fold with p value <0.01, significant correlation between serum level of IL-38 and IL-36R (r= -0.7459, p value =0.001), while weak correlation between concentration of IL-36R and mRNA expression of IL-38.ConclusionThe results showed that the changes in serum and expression levels of IL-38 have significant impact on asthma disease and its severity. These levels may account as diagnostic marker for pediatric asthma.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"10932607261495881"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10932607261495881","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundPediatric asthma is a respiratory disease involving bronchial hyperresponsiveness to risk factors, influenced by genetic and environmental factors.Objective: This study investigated IL-38/IL-36R in pediatric asthma. Samples from 140 children aged 1-10 years, including 80 patients and 60 controls, were analyzed. IL-38 mRNA expression was assessed by qRT-PCR, while serum IL-38 and IL-36R were measured by ELISA.ResultsRevealed significant increase serum level of IL-38 74.80± 11.583pg/ml in asthmatic patients compare to control 59.33± 11.833pg/ml (P=0.01) while serum level of IL-36R in patients 226.26 ±88.07 pg/ml compare to control group167.4250 ±55.03pg/ml, results of expression of mRNA level of IL-38 shows significantly increased in asthmatic patients 2 fold with p value <0.01, significant correlation between serum level of IL-38 and IL-36R (r= -0.7459, p value =0.001), while weak correlation between concentration of IL-36R and mRNA expression of IL-38.ConclusionThe results showed that the changes in serum and expression levels of IL-38 have significant impact on asthma disease and its severity. These levels may account as diagnostic marker for pediatric asthma.

小儿哮喘患者IL-38蛋白、mRNA表达水平及与IL-36R的相关性
儿童哮喘是一种呼吸系统疾病,涉及支气管对危险因素的高反应性,受遗传和环境因素的影响。目的:探讨IL-38/IL-36R在儿童哮喘中的作用。分析了140名1-10岁儿童的样本,包括80名患者和60名对照组。采用qRT-PCR检测IL-38 mRNA表达水平,ELISA检测血清IL-38、IL-36R水平。结果哮喘组血清IL-38水平(74.80±11.583pg/ml)较对照组(59.33±11.833pg/ml)显著升高(P=0.01), IL-36R水平(226.26±88.07 pg/ml)较对照组(167.4250±55.03pg/ml)显著升高(P=0.01), IL-38 mRNA表达水平在哮喘组显著升高2倍(P=0.01)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Antibodies
Human Antibodies Medicine-Immunology and Allergy
CiteScore
3.50
自引率
0.00%
发文量
27
期刊介绍: Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书